A research examines the epidemiology, transmission, and clinical presentation of COVID-19, with an emphasis on etiology and the potential use of liposomal GSH as an adjuvant therapy to current treatment methods in COVID-19 patients
Association between iron status markers and kidney outcome in patients with chronic kidney disease
I will also review landmark trials of different types of GLP1-RAs, cost effectiveness and their potential role in the protection from cardiovascular disease, including evidence on weight reduction, HBA1c reduction, systolic blood pressure control and improvement of both lipid and glycemic profiles
Caution is warranted in patients with a history of pancreatitis, severe gastrointestinal disease including gastroparesis, or diabetic retinopathy
Hormonal factors can blunt the response